← Eichor
Condition: Safety And Tolerability In Healthy Volunteers Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Safety And Tolerability In Healthy Volunteers

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HT31-1 for Treating ARDS
Phase 1 · 2 location(s) · HTIC, Inc · NCT07449572To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GB18 Injection in Health
Phase 1 · 1 location(s) · Shenzhen Kexing Pharmaceutical Co., Ltd. · NCT07237464Inhaled RB042 in Healthy Adult Volunteers and Healthy Adult Smokers
Phase 1 · 1 location(s) · Atisama Therapeutics · NCT07285122A Clinical Study of AK0610
Phase 1 · 1 location(s) · Shanghai Ark Biopharmaceutical Co., Ltd. · NCT06996704Safety, Tolerability, and Pharmacokinetics of Single Doses of HC022 in Healthy Subjects.
Phase 1 · 3 location(s) · HC Biopharma Inc. · NCT06657703A Phase 1a/1b Study to Investigate the Safety, Tolerability, Microbiological Response, and Pharmacokinetics of Inhaled R
Phase 1 · 1 location(s) · Revagenix, Inc. · NCT07709494A Clinical Study of SPH9788 Tablets in Healthy Chinese Subjects.
Phase 1 · 1 location(s) · Shanghai Pharmaceuticals Holding Co., Ltd · NCT06839131Safety, Tolerability, PK and PD of SSS55 in Healthy Subjects
Phase 1 · 1 location(s) · Shenyang Sunshine Pharmaceutical Co., LTD. · NCT07058779A Phase I/IIa Clinical Study to Assess the Single and Multiple Ascending Doses of MDR-001 Tablets in Healthy Participant
Phase 1/Phase 2 · 1 location(s) · MindRank AI Ltd · NCT06778850A Study of YP05002 in Healthy Participants
Phase 1 · 1 location(s) · Yaopharma Co., Ltd. · NCT07089823A Study to See How RO7763505 Works and How Safe it is When Given to Healthy People and People With Stable Heart Disease
Phase 1 · 1 location(s) · Hoffmann-La Roche · NCT07495813A Study of V118E in Healthy Participants (V118E-003)
Phase 1 · 4 location(s) · Merck Sharp & Dohme LLC · NCT07168915FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
Phase 1 · 5 location(s) · Pfizer · NCT06564389A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2061
Phase 1 · 1 location(s) · CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · NCT07241910A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics for a Single Dose of HRS-9821 Powder
Phase 1 · 1 location(s) · Guangdong Hengrui Pharmaceutical Co., Ltd · NCT07116915A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body of Hea
Phase 1 · 1 location(s) · Pfizer · NCT06994897A Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of AZD1613 in Healthy
Phase 1 · 1 location(s) · AstraZeneca · NCT06995820Phase I Study of MT1011 Injection in Healthy Subjects
Phase 1 · 1 location(s) · Shaanxi Micot Pharmaceutical Technology Co., Ltd. · NCT07024160A Study of Single and Multiple Ascending Doses of H021 in Healthy Participants
Phase 1 · 1 location(s) · Jiangsu Carephar Pharmaceutical Co., Ltd. · NCT06627556First-in-human Study of HSK56630 in Healthy Subjects
Phase 1 · 1 location(s) · Haisco Pharmaceutical Group Co., Ltd. · NCT07580794A Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RS-C1001 Tablets in Chinese Healthy Subjec
Phase 1 · 1 location(s) · Peking University First Hospital · NCT06669429A Study Investigating the Safety, Absorption, Elimination, and the Effect on the Immune System of ACI-19764 in Healthy P
Phase 1 · 1 location(s) · AC Immune SA · NCT07463196A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of APG-5918.
Phase 1 · 2 location(s) · Ascentage Pharma Group Inc. · NCT05773586Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia
Phase 1/Phase 2 · 4 location(s) · Absci Pty Ltd. · NCT07317544A First in Human Study of CMND-100 in Healthy and Alcohol Use Disorder (AUD) Subjects
Phase 1/Phase 2 · 4 location(s) · Clearmind Medicine Inc. · NCT05913752A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of INCA033989 Following Subcutaneous or Intravenous A
Phase 1 · 1 location(s) · Incyte Corporation · NCT07448155A Study of TAK-781 in Healthy Volunteers and in Participants With Non-Cirrhotic Primary Sclerosing Cholangitis (PSC)
Phase 1 · 1 location(s) · Takeda · NCT07229911Healthy Participants Randomized, Double-blind, Placebo-controlled, Phase Ⅰ
Phase 1 · 1 location(s) · First Affiliated Hospital of Zhejiang University · NCT07640438A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LWP779 in Healthy Participants
Phase 1 · 1 location(s) · Longwood Pharmaceuticals (Hangzhou) Co., Ltd. · NCT07371455A Study to Assess the Adverse Events and How Bretisilocin Intramuscular Injection Moves Through the Body of Healthy Adul
Phase 1 · 1 location(s) · AbbVie · NCT07604558
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.